Clinical Trial Update: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial of Reproxalap to Assess the Safety and Efficacy in Subjects With Dry Eye Disease [Phase 2]

View source ↗

Summary

Multi-center randomized Phase 2 trial evaluated the safety and efficacy of Reproxalap versus vehicle in dry eye disease. The study is completed and results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• Reproxalap (reproxalap)

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Dry Eye | Phase 2 | Status: COMPLETED | Results posted: 2025-03-03